RPRX
Royalty Pharma PlcPharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #672
- Final score
- 42.76
- Years on list
- 5
↘ Down 321 since 2021
Compare · Up to four Russell 1000 companies
Put them side by side
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
- RPRX· Royalty Pharma Plc
- HALO· Halozyme Therapeutics, Inc.
- BIO· Bio-Rad Laboratories, Inc.
Figure 01 · Side-by-side summary
The headline numbers
HALO
Halozyme Therapeutics, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #665
- Final score
- 42.98
- Years on list
- 1
BIO
Bio-Rad Laboratories, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2025
- #684
- Final score
- 42.06
- Years on list
- 6
↘ Down 39 since 2020
Figure 02 · Rank trajectory
Where each line is going
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2025
Where each one wins
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | RPRX | HALO | BIO |
|---|---|---|---|
| Climate Change | 41.2 | 45.8 | 41.9 |
| Employee Relations | 44.0 | 39.5 | 50.6 |
| Environment | 31.2 | 72.3 | 34.5 |
| Stakeholders & Society | 45.3 | 24.3 | 42.7 |
| Human Rights | 45.4 | 15.6 | 32.6 |
| Governance | 42.6 | 39.3 | 42.8 |
| Performance Rating | 79.4 | 54.1 | 55.7 |